The Weekly Wrap-Up provides summaries of recent publications from the Spin-Off Report including links to the full-length research reports. If you haven’t engaged with the research over the past seven days, the Weekly Wrap-Up will quickly update you on our newest and highest conviction ideas.
UPCOMING SPIN-OFFS AND EXPECTED COMPLETION DATES:
- Baxter International Inc. (BAX) / Vantive – 2Q 2024
- Jacobs Solutions Inc. (J) / Critical Mission Solutions – 3Q 2024
- Western Digital (WDC) / HDD Business – 2H 2024
- MDU Resources Group (MDU) / Construction Services – 2H 2024
- Berry Global Group Inc. (BERY) / HH&S And Films Businesses (to merge w/ Glatfelter) – 2H 2024
- Select Medical Holdings Corp. (SEM) / Concentra Business – 2H 2024
- Edwards Lifesciences Corp.(EW) / Critical Care Business – 2H 2024
- Holcim Ltd. (HOLN SW) / North American Business – 1H 2025
RECENT PUBLICATIONS:
ALERT: DUPONT TO SEPARATE INTO THREE INDEPENDENT COMPANIES VIA SPIN-OFFS
May 23, 2024
On May 22, 2024, after the market close, DuPont Inc. (NYSE: DD) announced its intention to separate into three independent publicly traded companies via tax free spin-offs of its Electronics and Water businesses. The separations are expected to be completed within 18 to 24 months.
DD describes itself as “a global innovation leader with technology-based materials and solutions … in key markets including electronics, transportation, construction, water, healthcare and worker safety.” The company generated $12.1 billion in revenue and $2.9 billion in operating EBITDA in 2023. As the company stands today it reports under two segments: Electronics & Industrial (44% of 2023 sales), and Water & Protection (47% of 2023 sales). (Corporate and other account for the remaining ~9% of sales.)
Electronics & Industrial (E&I) provides a broad portfolio of materials and components used in high performance computing, electric vehicles, and mobile devices, amongst others, to the aerospace, defense, transportation, healthcare and medical device industries.
Water & Protection (W&P) provides engineered products and integrated systems across multiple industries including worker safety, water purification, transportation, energy, and medical packaging, amongst others. W&P business lines include Safety Solutions, Shelter Solutions, and Water Solutions.
The New Electronics company will be comprised of the current Semiconductor Technologies and Interconnect Solutions businesses (currently in E&I), as well as certain electronics related businesses from the current Industrial Solution business. Applications to be controlled by the New Electronics company include integrated circuit fabrication for memory and logic semiconductors, as well as printed circuit board, electronic and industrial finishing.
The New Water company will control the current Water Solutions business line (currently in W&S) and offers products and solutions for water filtration, purification, reverse osmosis, ion exchange, and ultrafiltration.
Following the separation, the parent DuPont company, New DuPont, will remain a diversified industrial company controlling a range of material science and application expertise with well-known brand names such as Tyvek, Kevlar, and Nomex. End market exposure is expected to focus on healthcare, and electric vehicles, while remaining an active participant in the safety, construction, and aerospace end markets, amongst others. Absent New Electronics, and New Water’s contribution, New DuPont would have generated $6.6 billion in revenue and operated with an approximate EBITDA margin of 24% in 2023.
In terms of rationale, investor appetite for more specialized companies, particularly in the water and electronics businesses, may result in an unlocking of value. New Water and New Electronics should exhibit faster growth rates than the current conglomerate and a set of focused peer comps currently trade at higher forward multiples than the current DD. Water peers trade at approximately 19.5x forward EBITDA estimates, and Electronic peers trade at 22.5x forward EBITDA. DD currently trades at 13.0x forward EBITDA, which is roughly in line with other diversified industrial companies.
Management issued 2024 guidance that includes revenue between $12.1 and $12.4 billion, and EBITDA between $2.9 and $3.05 billion. At the midpoint, this implies a 2.5% decline in revenue and a 1.1% increase in EBITDA. Management cites improving trends in electronics, and reduced channel destocking in their guidance. Based on the post-spin companies 2023 revenue and EBITDA margins, and assuming a modest recovery starting in 2H 2024 and continuing through 2025, its reasonable the post spin companies would be able to earn $1.5 billion, $1.1 billion, and $355 million in respective 2025 EBITDA for New DuPont, New Electronics, and New Water. Valuing each piece at a slight discount their respective peer set, and incorporating current net debt and shares outstanding, on a preliminary sum-of-the-parts basis, shares of pre-spin DuPont could be assigned a fair value estimate of $90 per share (14% upside from the current DD share price).
BAXTER INTERNATIONAL INC. (BAX) / VANTIVE – COMPREHENSIVE REPORT
May 13, 2024
In March 2024, BAX disclosed that “it has been in recent discussions with select private equity investors to explore a potential sale of the Kidney Care asset in lieu of the proposed spin-off of the business.” While no final decision has been made on the ultimate form of the Kidney Care separation, management stated it is committed to “separating“ the business in 2H 2024. The standalone business, if spun off, is expected to adopt the corporate moniker Vantive.
The removal of the lower-margin Kidney Care business will significantly improve overall profitability measures for the parent company, Baxter. While management is targeting 4% – 5% topline growth, it has emphasized a focus on improving overall profitability and is willing to see slower growth in the near term. Absent Kidney Care segment contributions, consolidated margins would have widened by 310 basis points each year, on average.
BAX currently trades at 8.7x and 11.3x its consensus 2024 EBITDA and EPS estimates, respectively. In relation to its discounted multiple to the medical device and supplies peer set, it should be noted that BAX as a whole operates with an EBITDA margin that is roughly 800 basis points below that of the low-end performing peers and roughly in line with that of the Kidney Co. peers. Absent Kidney Co., BAX’s margins should expand, so as to narrow the margin discrepancy, although still remaining below its peers.
Valuing the post-spin companies at 9.0x for Vantive, roughly in line with the current BAX multiple, and 12.0x for post-spin Baxter equates to respective fair enterprise values of $5.2 billion and $28.0 billion. Based on current net debt and shares outstanding, we assign a pre-spin sum-of-the-parts fair value estimate of $43 per share (26% upside from the current share price) and we rate pre-spin shares of Baxter International at BUY.
If the company is able to attract a private equity buyer for the Kidney Care business, it may provide further upside to our valuation. The low end of recent M&A valuations for medical device and supply companies is near 12x forward EBITDA estimates. If Vantive were to be valued at 12x our 2025 EBITDA figure, our fair value estimate would increase by $4 per share.
Radar Screen – May 2024
Monthly publication providing ongoing analysis on companies where we see potential for a value-unlocking event
Companies discussed this month: Albany International (AIN), Alphabet Inc. (GOOG), APi Group Corp. (APG), Bloomin’ Brands (BLMN), California Resources Corp. (CRC), Carrier Global Corp. (CARR), Crown Castle Inc. (CCI), Goodyear Tire & Rubber, Inc. (FLT), IAC Inc. (IAC), Liberty Broadband Corp. (LBRDK), Masimo Corp. (MASI), Matthews International Corp. (MATW), Natura & Co. (NTCO), Newpark Resources (NR), PAR Technology Corp. (PAR), RCI Hospitality Inc. (RICK), Stanley Black & Decker (SWK)*, TFI International (TFII), TriMas Corporation (TRS)
*New Entry this Month
Spin-Off Report Calendar – May 2024
Published monthly, The Spin-Off Calendar provides one-page summaries of every spin-off under coverage from the announcement date, followed by the filing of the Form 10 and continuing 60 days post completion.
Spin-Off Report Compendium – March 2024
Murray Stahl’s commentary on various investing themes and single stock recommendations.
European Spin-Off Compendium – April 2024
Murray Stahl’s commentary on various investing themes and single stock recommendations in Europe.
Bits & Pieces – May 2024
Covers mispriced stub securities, tracking stocks and other arbitrage opportunities.
Product Specialist
Rich Albanese
ralbanese@pcsresearchgroup.com
+1 646-839-5566